Terminated NA INTERVENTIONAL 1-arm NCT00627861

Combined Renin Inhibition/Beta-blockade

Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade

Sponsor: The Rogosin Institute

Interventions Aliskiren Extended-release metoprolol

Updated 7 times since 2017 Last updated: Oct 26, 2015 Started: Nov 30, 2008 Primary completion: May 31, 2010 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The renin laboratory used in the study is no longer available.

Other terminated trials from The Rogosin Institute

Adolescent Obesity · Phase NA · Jun 2019

See all terminations from The Rogosin Institute

Other Hypertension trials with similar outcome

Browse all Hypertension trials

This NA trial investigates Hypertension and is currently terminated or withdrawn. The Rogosin Institute leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA
Jan 2021 — Dec 2022 [monthly]

Terminated NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Rogosin Institute

Data source: The Rogosin Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States